IP Library Granted Patent US 11,786,451
Granted Patent B2
US 11,786,451 · App. 16/455,988 · Granted Oct 17, 2023

Skin care composition

Inventors: Tomohiro Hakozaki (Cincinnati, OH); Bin Fang Deyer (Loveland, OH); Leo Timothy Laughlin, II (Mason, OH)
Assignee: The Procter & Gamble Company
A61K8/675A61K8/04A61K8/29A61K8/342A61K8/347A61K8/368A61K8/86A61K8/891A61K8/9783A61Q19/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,451
App. No.
16/455,988
Granted
Oct 17, 2023
Kind
B2
Abstract

Methods and compositions for improving the appearance of skin are provided. The methods and compositions are especially suited for inhibiting activation of PAR2 in skin by utilizing a synergistic combination of a water lily extract and vitamin B 3 compound. The method involves treating hyperpigmented skin by applying a skin care composition containing an effective amount of a combination of water lily extract and vitamin B 3 compound to a target portion of skin over the course of a treatment period.

Claims (37)

1. A method of synergistically inhibiting PAR2 activation, comprising:

a) identifying a target portion of skin on a person where treatment is desired; and

b) applying a composition comprising:

i) a hydrolysate comprising an aqueous extract of Nymphaea alba flowers and thermally inactivated enzymes; wherein the hydrolysate comprises from about 20% to about 70% carbohydrate, by weight of the dry matter of the hydrolysate; and

ii) a vitamin B 3 compound;

wherein the composition targets a portion of skin during a treatment period,

wherein the hydrolysate and vitamin B 3 compound are present at a volume/weight ratio of hydrolysate to niacinamide of 1:4 to 5:1.

2. The method of claim 1 , wherein the hydrolysate and vitamin B 3 compound are present at a volume/weight ratio of hydrolysate to vitamin B 3 of 1:2 to 2.5:1.

3. The method of claim 1 , wherein the vitamin B 3 compound is niacinamide.

4. The method of claim 2 , wherein the niacinamide is present at about 0.0001% to about 10% by weight of the composition.

5. The method of claim 1 , wherein the composition comprises about 0.00001% to about 10% hydrolysate, by weight, based on the weight of the composition.

6. The method of claim 5 , wherein the synergistic inhibition of PAR2 activation is at least 10% more than a calculated additive effective according to the PAR2 Inhibition Assay.

7. A topical skin care composition, comprising:

a) about 0.4%, by weight of the skin care composition, of a hydrolysate comprising an aqueous extract of Nymphaea alba flowers and thermally inactivated enzymes; wherein the hydrolysate comprises from about 20% to about 70% carbohydrate, by weight of the dry matter of the hydrolysate; and

b) about 5%, by weight of the skin care composition, of a vitamin B 3 compound;

c) a dermatologically acceptable carrier.

8. The skin care composition of claim 7 , wherein the vitamin B 3 compound is niacinamide and is present at about 0.001% to about 10% by weight of the composition.

9. The skin care composition of claim 7 , wherein the composition comprises about 0.0001% to about 10% hydrolysate, by weight, based on the weight of the composition.

10. The skin care composition of claim 7 , wherein the hydrolysate comprises about 20% to about 60% mineral based on the weight of the dry matter.

11. The skin care composition of claim 7 , wherein the hydrolysate comprises less than about 3% polyphenol based on the weight of the dry matter of the hydrolysate.

12. The skin care composition of claim 7 , wherein the composition further comprises at least one additional ingredient chosen from vitamins, minerals, sugar amines, sunscreen agents, oil control agents, flavonoid compounds, anti-oxidants, preservatives, protease inhibitors, tyrosinase inhibitors, anti-inflammatory agents, moisturizing agents, exfoliating agents, skin lightening agents, lubricants, anti-acne actives, chelating agents, anti-wrinkle actives, anti-atrophy actives, phytosterols, N-acyl amino acid compounds, antimicrobials, and antifungals, conditioning agents, emulsifiers, rheology modifiers, or mixtures thereof.

13. The skin care composition of claim 12 , wherein the additional ingredient includes a superabsorbent polymer thickening agent chosen from sodium polyacrylate, starch grafted sodium polyacrylate, or mixtures thereof.

14. The method of claim 1 , wherein the hydrolysate comprises less than 15% peptide, based on the weight of dry matter of the hydrolysate.

15. The method of claim 1 , wherein the hydrolysate comprises less than 10% peptide, based on the weight of dry matter of the hydrolysate.

16. The skin care composition of claim 7 , wherein the hydrolysate comprises less than 15% peptide, based on the weight of dry matter of the hydrolysate.

17. A topical skin care composition, comprising:

a) about 0.4%, by weight of the skin care composition, of a hydrolysate comprising an aqueous extract of Nymphaea alba flowers and thermally inactivated enzymes; wherein the hydrolysate comprises from about 20% to about 70% carbohydrate, by weight of the dry matter of the hydrolysate; and

b) about 5%, by weight of the skin care composition, of a niacinamide;

c) about 5%, by weight of the skin care composition, glycerin; and

d) water.

18. The topical skin care composition of claim 17 , wherein the composition further comprises:

a) about 2%, by weight of the composition, dimethicone/ dimethiconol

b) about 0.5%, by weight of the composition, dexpanthenol; and

c) tocopherol acetate.

19. The topical skin care composition of claim 18 , wherein the composition further comprises:

about 0.05%, by weight of the composition, disodium EDTA; and

about 0.1%, by weight of the composition, PEG-100 Stearate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2019
From: HAKOZAKI, TOMOHIRO NMN; FANG DEYER, BIN NMN; LAUGHLIN, LEO TIMOTHY, II
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 050499/0091 →
Continuity (1)
Related Publication 20200405614A1 · Dec 31, 2020